Prothena Corp
PRTA
125 hedge funds and large institutions have $610M invested in Prothena Corp in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 35 increasing their positions, 37 reducing their positions, and 39 closing their positions.
46% more call options, than puts
Call options by funds: $9.92M | Put options by funds: $6.78M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 37
4.81% less ownership
Funds ownership: 109.83% → 105.03% (-4.8%)
12% less funds holding
Funds holding: 142 → 125 (-17)
44% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 39
61% less capital invested
Capital invested by funds: $1.55B → $610M (-$941M)
Top Buyers
| 1 |
SCM
Scopia Capital Management
New York
|
+$69.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$33.1M |
| 3 |
DM
Deerfield Management
New York
|
+$12.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.5M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$10.6M |
Top Sellers
PRTA Hedge Fund Activity: Q2 2018 in Review
125 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Prothena Corp (PRTA) for Q2 2018, worth a combined $610M — down 61% from $1.55B a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of PRTA and 22 opened new positions — a net loss of 17 holders — while 37 trimmed existing stakes and 35 added.
The largest buyer was Scopia Capital Management, opening a new position worth an estimated $69.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $96.4M.
- 125 institutional investors held Prothena Corp (PRTA) as of Q2 2018, down from 142 in Q1 2018.
- Funds reported $610M of Prothena Corp stock for Q2 2018, down 61% quarter-over-quarter.
- 22 funds opened new Prothena Corp positions in Q2 2018 and 39 closed out, a net change of -17 holders.
- The largest Prothena Corp buyer in Q2 2018 was Scopia Capital Management, an estimated $69.4M added.
- The largest Prothena Corp seller in Q2 2018 was T. Rowe Price Associates, an estimated $96.4M sold.
Based on aggregated 13F filings for Q2 2018.